0,909  0,003  GST A substrate
0,884  0,004  Eye irritation, high
0,855  0,004  Skin irritative effect
0,807  0,010  Caspase 9 stimulant
0,713  0,002  GST P1-1 substrate
0,702  0,030  Antiinflammatory
0,685  0,016  Embryotoxic
0,673  0,010  Sensitization
0,680  0,018  Teratogen
0,661  0,011  Cholesterol antagonist
0,632  0,012  Vasodilator, peripheral
0,623  0,006  Platelet antagonist
0,652  0,039  Apoptosis agonist
0,632  0,020  TNF expression inhibitor
0,617  0,016  Respiratory analeptic
0,601  0,003  GST M1-1 substrate
0,588  0,016  Antiallergic
0,578  0,015  Analeptic
0,569  0,009  FMO1 substrate
0,558  0,009  Antiglaucomic
0,554  0,014  GABA C receptor rho-3 antagonist
0,539  0,008  Sedative
0,537  0,006  Antiulcerative
0,547  0,020  Antipruritic, allergic
0,532  0,007  Carcinogenic, group 3
0,535  0,016  Lipoprotein disorders treatment
0,541  0,024  Antithrombotic
0,536  0,018  Mutagenic
0,531  0,018  Cardioprotectant
0,524  0,012  Tumour necrosis factor alpha release inhibitor
0,514  0,010  Antimutagenic
0,528  0,023  Antihypercholesterolemic
0,522  0,020  Chemoprotective
0,526  0,026  Immunosuppressant
0,533  0,040  Transcription factor NF kappa B inhibitor
0,496  0,008  Anesthetic general
0,498  0,011  UGT2B4 substrate
0,507  0,023  Carcinogenic
0,495  0,013  Hypolipemic
0,504  0,022  Radioprotector
0,485  0,004  Protein kinase stimulant
0,484  0,006  Abortion inducer
0,496  0,023  Antifungal
0,475  0,006  VCAM1 expression inhibitor
0,482  0,022  NOS3 expression inhibitor
0,479  0,021  NOS2 expression inhibitor
0,467  0,009  Septic shock treatment
0,465  0,013  Antihypoxic
0,489  0,038  CYP2C9 substrate
0,455  0,008  Phospholipase C inhibitor
0,461  0,021  Antiprotozoal (Leishmania)
0,463  0,025  Apoptosis antagonist
0,448  0,016  Vasodilator
0,445  0,014  Platelet aggregation inhibitor
0,460  0,033  CYP2C19 substrate
0,461  0,036  CYP2C19 inhibitor
0,432  0,010  Hair growth stimulant
0,439  0,017  Radiosensitizer
0,447  0,030  Caspase 3 stimulant
0,426  0,012  FMO3 substrate
0,417  0,008  Antipruritic, non-allergic
0,439  0,031  AR expression inhibitor
0,429  0,030  Antioxidant
0,423  0,026  Chemopreventive
0,416  0,021  Antineoplastic (liver cancer)
0,404  0,013  5 Hydroxytryptamine uptake stimulant
0,421  0,032  Lipoxygenase inhibitor
0,399  0,012  Anesthetic
0,389  0,006  Aldehyde dehydrogenase inhibitor
0,425  0,043  Immunostimulant
0,398  0,022  Antihypertriglyceridemic
0,379  0,005  Carcinogenic, group 1
0,409  0,036  Antineoplastic (pancreatic cancer)
0,394  0,023  Angiogenesis stimulant
0,420  0,050  Ulceration
0,391  0,022  Antineoplastic (endocrine cancer)
0,427  0,059  Antineoplastic (lung cancer)
0,372  0,014  Melanin inhibitor
0,354  0,003  Antiprotozoal activity enhancer
0,381  0,031  Antipyretic
0,381  0,032  Proliferative diseases treatment
0,408  0,061  Antileukemic
0,375  0,028  Antiparasitic
0,374  0,029  Nitric oxide antagonist
0,349  0,004  Antifungal (Cryptococcus)
0,376  0,034  DNA damaging
0,346  0,004  Toll-Like receptor 2 antagonist
0,410  0,071  Histamine release inhibitor
0,348  0,011  Gastrin inhibitor
0,361  0,029  Transcription factor STAT3 inhibitor
0,349  0,020  Platelet adhesion inhibitor
0,335  0,007  Succinate dehydrogenase inhibitor
0,364  0,038  Antineoplastic (multiple myeloma)
0,325  0,004  Photosensitizer
0,351  0,031  Flavin-containing monooxygenase substrate
0,361  0,043  Calcium channel activator
0,352  0,038  Free radical scavenger
0,322  0,008  GABA C receptor agonist
0,392  0,080  Antibacterial
0,315  0,004  UGT2B10 substrate
0,366  0,060  Bone diseases treatment
0,347  0,042  Cytostatic
0,314  0,012  Glutathione S-transferase substrate
0,346  0,044  Cytotoxic
0,383  0,082  15-Lipoxygenase inhibitor
0,306  0,007  Adenylate kinase inhibitor
0,326  0,027  RNA-directed DNA polymerase inhibitor
0,361  0,062  Prostate cancer treatment
0,305  0,006  Antieczematic
0,304  0,006  Antispirochetal
0,382  0,085  Antineoplastic (breast cancer)
0,317  0,023  UGT2B7 substrate
0,333  0,041  Insulysin inhibitor
0,320  0,028  Antihelmintic
0,317  0,025  Non-steroidal antiinflammatory agent
0,306  0,017  Tumour necrosis factor antagonist
0,331  0,041  Antidiabetic symptomatic
0,351  0,061  ICAM1 expression inhibitor
0,307  0,019  Interferon gamma antagonist
0,294  0,006  GABA C receptor rho-2 antagonist
0,314  0,027  Tyrosine 3 hydroxylase inhibitor
0,304  0,017  Antihelmintic (Nematodes)
0,321  0,037  Antineoplastic (lymphocytic leukemia)
0,342  0,058  5 Hydroxytryptamine release stimulant
0,313  0,030  Growth hormone agonist
0,306  0,024  DNA methyltransferase I inhibitor
0,290  0,009  Interleukin 4 antagonist
0,322  0,044  Transcription factor STAT inhibitor
0,333  0,056  CTGF expression inhibitor
0,316  0,040  UGT1A6 substrate
0,336  0,061  Antineoplastic (ovarian cancer)
0,286  0,013  Cholesterol synthesis inhibitor
0,293  0,020  CYP2B6 inhibitor
0,290  0,018  Insulin sensitizer
0,324  0,054  Antineoplastic (osteosarcoma)
0,299  0,030  Hepatoprotectant
0,277  0,009  ATPase inhibitor
0,299  0,031  UGT1A4 substrate
0,276  0,010  Uterine stimulant
0,283  0,018  Genotoxic
0,308  0,045  Antineoplastic (glioblastoma multiforme)
0,283  0,022  Skin whitener
0,284  0,024  UGT1A3 substrate
0,294  0,034  UGT1A1 substrate
0,280  0,020  Monophenol monooxygenase inhibitor
0,286  0,032  DNA methylase inhibitor
0,298  0,044  DNA synthesis inhibitor
0,257  0,005  Vanilloid agonist
0,303  0,051  Cardiodepressant
0,318  0,067  CYP3A4 inhibitor
0,256  0,005  TRPA1 agonist
0,306  0,056  Antineoplastic (glioma)
0,320  0,071  CYP2D6 substrate
0,252  0,004  Adenylate cyclase stimulant
0,304  0,056  Antineoplastic (cervical cancer)
0,319  0,072  Immunomodulator
0,263  0,020  Phospholipase A2 inhibitor
0,246  0,004  Toll-Like receptor 4 antagonist
0,262  0,021  Interleukin 6 antagonist
0,247  0,006  Arachidonic acid antagonist
0,312  0,071  Antipsoriatic
0,255  0,014  Cystathionine beta-synthase inhibitor
0,249  0,009  Microtubule formation inhibitor
0,249  0,010  Alcohol dehydrogenase substrate
0,306  0,068  Antineoplastic (melanoma)
0,265  0,027  Antiacne
0,263  0,027  Skeletal muscle relaxant
0,239  0,004  GABA aminotransferase inhibitor
0,251  0,020  UGT2B9 substrate
0,234  0,005  GABA C receptor rho-1 antagonist
0,254  0,029  Antiseptic
0,231  0,007  Vanilloid 1 agonist
0,232  0,008  GABA C receptor antagonist
0,234  0,011  Choleretic
0,316  0,095  Stroke treatment
0,246  0,028  UGT2B15 substrate
0,300  0,082  Hepatic disorders treatment
0,342  0,125  Antiarthritic
0,224  0,007  Carcinogenic, group 2A
0,221  0,004  Glycine receptor agonist
0,224  0,007  ErbB-3 antagonist
0,239  0,022  Anesthetic local
0,282  0,068  UGT1A9 substrate
0,279  0,065  Antineoplastic (non-small cell lung cancer)
0,252  0,041  Muscle relaxant
0,232  0,022  Antifungal enhancer
0,231  0,021  Toll-Like receptor antagonist
0,222  0,012  Catalase inhibitor
0,307  0,097  CYP3A4 substrate
0,216  0,008  Transcription factor NF kappa B stimulant
0,239  0,033  Antineoplastic (carcinoma)
0,224  0,018  Neurotrophic factor
0,239  0,034  Protein-tyrosine phosphatase inhibitor
0,226  0,020  Alkylator
0,212  0,007  Thioredoxin inhibitor
0,269  0,064  Cardiovascular analeptic
0,269  0,064  Vascular (periferal) disease treatment
0,282  0,077  CYP1A2 substrate
0,222  0,018  Ferrochelatase inhibitor
0,207  0,003  Lysophosphatidic acid 2 receptor antagonist
0,231  0,028  Antidote
0,208  0,006  Prostaglandin EP2 antagonist
0,230  0,028  Corneal wound healing stimulator
0,280  0,078  Spasmolytic
0,211  0,011  Aldehyde dehydrogenase substrate
0,242  0,044  Pneumotoxic
0,291  0,095  Vasodilator, coronary
0,263  0,067  Superoxide dismutase inhibitor
0,251  0,055  Antihypotensive
0,217  0,022  Antirickettsial
0,206  0,010  Phosphofructokinase-1 inhibitor
0,214  0,019  Antibacterial (Helicobacter pylori)
0,202  0,010  Glutamate dehydrogenase inhibitor
0,197  0,005  Glutathione S-transferase inhibitor
0,215  0,024  DNA polymerase I inhibitor
0,218  0,029  Alpha-N-acetylglucosaminidase inhibitor
0,222  0,034  Muscular dystrophy treatment
0,211  0,024  Catenin beta inhibitor
0,213  0,027  Cocaine dependence treatment
0,197  0,013  Gastric antisecretory
0,209  0,027  Protein-tyrosine phosphatase 1B inhibitor
0,253  0,071  5 Hydroxytryptamine 1E antagonist
0,201  0,020  Antiviral (Poxvirus)
0,196  0,014  Mucolytic
0,201  0,020  Expectorant
0,266  0,086  Hypoxia-inducible factor 1 alpha inhibitor
0,247  0,068  Antineoplastic (lymphoma)
0,254  0,076  Interleukin agonist
0,183  0,006  Ca2+-transporting ATPase inhibitor
0,244  0,067  Cyclic AMP phosphodiesterase inhibitor
0,194  0,017  Coagulant
0,239  0,063  Psychostimulant
0,193  0,017  UGT2B1 substrate
0,191  0,015  Contraceptive female
0,250  0,075  Myocardial infarction treatment
0,252  0,078  Antineoplastic (renal cancer)
0,219  0,045  Histone acetyltransferase inhibitor
0,220  0,046  Antiviral (Hepatitis)
0,186  0,011  Prolactin inhibitor
0,194  0,021  Cyclooxygenase 3 inhibitor
0,259  0,086  Antiosteoporotic
0,176  0,004  Oleamide hydrolase inhibitor
0,189  0,018  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,185  0,014  Antiviral (Influenza B)
0,176  0,007  UGT2B11 substrate
0,315  0,149  5 Hydroxytryptamine release inhibitor
0,205  0,039  Antiviral (Hepatitis C)
0,178  0,013  Heat shock protein 70 antagonist
0,175  0,014  Triose-phosphate isomerase inhibitor
0,188  0,028  Cell adhesion inhibitor
0,178  0,019  Antineoplastic, alkylator
0,202  0,044  Amylase inhibitor
0,240  0,083  Hypoglycemic
0,166  0,011  Anabolic
0,172  0,017  Arylamine N-Acetyltransferase substrate
0,163  0,010  Acetylcholine release stimulant
0,188  0,035  Cell wall synthesis inhibitor
0,161  0,008  Ornithine decarboxylase inhibitor
0,154  0,003  Lysophosphatidic acid 3 receptor antagonist
0,162  0,011  Glutamate decarboxylase inhibitor
0,169  0,018  Calcium antagonist
0,165  0,019  Caspase 3 inhibitor
0,155  0,009  Amidase inhibitor
0,159  0,014  Antifungal (Pneumocystis)
0,211  0,066  Neurotrophic factor enhancer
0,154  0,009  Leukotriene synthesis inhibitor
0,149  0,006  Narcotic antagonist
0,147  0,005  Phosphate transporter inhibitor
0,156  0,014  GST T1-1 substrate
0,146  0,004  Prostaglandin agonist
0,165  0,023  Mediator release inhibitor
0,157  0,017  Electrolyte absorption antagonist
0,145  0,005  Endocannabinoid uptake inhibitor
0,148  0,009  Acyl-CoA dehydrogenase inhibitor
0,168  0,030  Beta amyloid protein antagonist
0,142  0,004  Aconitate hydratase inhibitor
0,172  0,035  Proteasome inhibitor
0,171  0,035  MAO A inhibitor
0,160  0,025  Carbonic anhydrase III inhibitor
0,166  0,032  Carcinogenic, group 2B
0,138  0,005  Prostaglandin F2 alpha antagonist
0,135  0,004  Anesthetic inhalation
0,180  0,050  Lipid peroxidase inhibitor
0,152  0,022  Myasthenia Gravis treatment
0,240  0,111  Antiischemic
0,149  0,021  Actinic keratosis treatment
0,191  0,065  Diabetic retinopathy treatment
0,174  0,048  Raynaud's phenomenon treatment
0,240  0,115  12-Lipoxygenase inhibitor
0,137  0,012  Leukotriene antagonist
0,133  0,009  Antidote, heavy metal
0,175  0,053  NOS3 expression enhancer
0,150  0,028  Antineoplastic alkaloid
0,156  0,034  Excitatory amino acid transporter EAAC1 inhibitor
0,247  0,126  Angiogenesis inhibitor
0,133  0,012  Glycine receptor antagonist
0,245  0,125  Antihypertensive
0,132  0,014  Lipase inhibitor
0,121  0,005  Squalene synthetase inhibitor
0,140  0,024  Carbonic anhydrase XIII inhibitor
0,189  0,073  Sepsis treatment
0,199  0,084  Interleukin antagonist
0,123  0,009  Estrogen-related receptor beta agonist
0,133  0,020  Lanosterol 14 alpha demethylase inhibitor
0,136  0,024  Porphobilinogen synthase inhibitor
0,116  0,005  Fumarate hydratase inhibitor
0,130  0,018  Restless leg syndrome treatment
0,176  0,065  Phobic disorders treatment
0,166  0,056  Antineoplastic (squamous cell carcinoma)
0,170  0,061  Acaricide
0,112  0,003  Membrane dipeptidase inhibitor
0,130  0,022  Antidote, mercury
0,147  0,039  5-Lipoxygenase inhibitor
0,130  0,022  Tourette's syndrome treatment
0,170  0,063  Neurotensin receptor agonist
0,162  0,055  Hemostatic
0,217  0,111  Amyotrophic lateral sclerosis treatment
0,121  0,015  Granulocyte macrophage colony stimulating factor agonist
0,131  0,027  Interleukin 1 beta converting enzyme inhibitor
0,187  0,083  Antiviral (Influenza)
0,151  0,048  Antihyperlipoproteinemic
0,134  0,032  DOPA decarboxylase inhibitor
0,109  0,007  Potassium channel Kv1.3 blocker
0,134  0,032  Electron transport complex I inhibitor
0,145  0,043  Antineoplastic antimetabolite
0,169  0,068  Thrombolytic
0,114  0,014  Elastase 1 inhibitor
0,177  0,077  LDLR expression enhancer
0,162  0,064  Antiviral (Influenza A)
0,112  0,014  Ornithine carbamoyltransferase inhibitor
0,107  0,010  Antimycoplasmal
0,099  0,003  Kainate receptor agonist
0,129  0,032  Folate antagonist
0,105  0,010  Antiviral (Parainfluenza)
0,114  0,020  Na+ K+ transporting ATPase inhibitor
0,182  0,090  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,116  0,025  Glutamate release inhibitor
0,109  0,018  Carbamoyl phosphate synthetase inhibitor
0,100  0,009  Exportin-1 inhibitor
0,137  0,047  Sphingosine 1-phosphate receptor 4 antagonist
0,101  0,011  Thromboxane antagonist
0,098  0,009  CD45 antagonist
0,118  0,030  Carbonic anhydrase VI inhibitor
0,098  0,011  Leukotriene B4 antagonist
0,155  0,067  CF transmembrane conductance regulator agonist
0,089  0,002  Prostaglandin F2 alpha agonist
0,109  0,023  Interferon agonist
0,115  0,029  Antifungal (Candida)
0,090  0,004  Methionyl aminopeptidase 1 inhibitor
0,149  0,063  Cytokine production inhibitor
0,109  0,025  Nicotinic alpha4beta2 receptor antagonist
0,089  0,005  Adenylate cyclase 1 inhibitor
0,145  0,062  Renal failure treatment
0,093  0,009  Thromboxane A2 antagonist
0,088  0,005  Ryanodine receptor antagonist
0,089  0,006  Glucose-6-phosphate isomerase inhibitor
0,189  0,107  Antiamyloidogenic
0,170  0,088  Wound healing agent
0,247  0,166  CYP2C9 inhibitor
0,096  0,015  Cathepsin E inhibitor
0,135  0,054  Gastritis treatment
0,149  0,069  Thiol protease inhibitor
0,093  0,013  Nitric oxide donor
0,094  0,013  Glutamate (mGluR6) antagonist
0,110  0,030  Cathepsin G inhibitor
0,104  0,026  Peroxisome proliferator-activated receptor gamma agonist
0,096  0,018  TRPA1 antagonist
0,087  0,009  Thromboxane synthase inhibitor
0,113  0,036  Interleukin 12 antagonist
0,084  0,007  Leukotriene C antagonist
0,094  0,017  Antimetabolite
0,108  0,031  Tocolytic
0,198  0,122  Antiprotozoal (Trypanosoma)
0,090  0,015  Toll-Like receptor 2 agonist
0,078  0,004  Prostaglandin D2 agonist
0,146  0,072  Antianemic
0,138  0,065  Tubulin antagonist
0,078  0,004  Prostaglandin E2 agonist
0,101  0,027  Caspase 7 inhibitor
0,103  0,031  Histidine decarboxylase inhibitor
0,093  0,021  Biliverdin reductase inhibitor
0,243  0,171  Atherosclerosis treatment
0,109  0,037  Phosphodiesterase 6D inhibitor
0,107  0,036  Bile acid receptor antagonist
0,074  0,004  Prostacyclin agonist
0,088  0,018  Interferon inducer
0,166  0,096  UDP-glucuronosyltransferase substrate
0,096  0,027  Sphingosine 1-phosphate receptor 4 agonist
0,103  0,035  Antileprosy
0,128  0,060  Antiprotozoal (Amoeba)
0,077  0,010  Adenosine deaminase inhibitor
0,117  0,049  Xanthine oxidase inhibitor
0,091  0,024  Vanilloid 4 agonist
0,096  0,029  T cell inhibitor
0,096  0,029  Selectin antagonist
0,090  0,024  Anticholelithogenic
0,177  0,111  Antialcoholic
0,085  0,020  Carbonic anhydrase VB inhibitor
0,091  0,026  Antidote, organophosphates
0,069  0,006  Melatonin 2 agonist
0,102  0,039  Interleukin 5 antagonist
0,072  0,010  Retinoid X receptor agonist
0,193  0,131  Antiviral (West Nile virus)
0,094  0,031  CDC25A inhibitor
0,109  0,047  HIV-1 integrase (Overall Integration) inhibitor
0,072  0,012  Pregnane X receptor antagonist
0,134  0,073  Bone formation stimulant
0,063  0,003  Lysophosphatidic acid receptor 1 agonist
0,099  0,041  ATPase (Vacuolar H+) inhibitor
0,072  0,014  HCV NS3/NS4A protease inhibitor
0,195  0,137  Antineoplastic (colorectal cancer)
0,160  0,102  P-glycoprotein inhibitor
0,059  0,002  Carbonic anhydrase VIII inhibitor
0,059  0,002  Carbonic anhydrase X inhibitor
0,059  0,002  Lysophosphatidic acid receptor 3 agonist
0,062  0,005  Melatonin receptor 1A agonist
0,139  0,084  Cytidine deaminase inhibitor
0,138  0,085  Neuropeptide Y1 antagonist
0,064  0,011  Factor XIIIa inhibitor
0,120  0,067  Adenylate cyclase inhibitor
0,129  0,076  CNS active muscle relaxant
0,142  0,089  Movement disorders treatment
0,069  0,017  Antiviral (Herpesvirus 3, Human)
0,172  0,120  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,082  0,030  Hyperparathyroidism treatment
0,058  0,006  Leukotriene C4 antagonist
0,171  0,120  Antineoplastic enhancer
0,094  0,043  Inducible nitric-oxide synthase inhibitor
0,072  0,021  Peroxisome proliferator-activated receptor alpha agonist
0,124  0,073  Papain-like protease (SARS coronavirus) inhibitor
0,060  0,009  Prostacyclin antagonist
0,054  0,004  Calcium-independent phospholipase A2 inhibitor
0,104  0,054  Nitric-oxide synthase inhibitor
0,090  0,041  Thioredoxin reductase inhibitor
0,089  0,040  Antibiotic
0,088  0,040  Keratolytic
0,072  0,024  Fatty acid synthase inhibitor
0,115  0,068  Interleukin 8 antagonist
0,131  0,084  Antianorexic
0,077  0,030  Protease 3C (Human rhinovirus) inhibitor
0,082  0,035  Carbonic anhydrase VA inhibitor
0,080  0,034  Peroxisome proliferator-activated receptor gamma antagonist
0,068  0,024  Postcoital contraceptive
0,143  0,100  Hearing loss treatment
0,052  0,010  Glutamate (mGluR8) agonist
0,075  0,033  Antiemphysemic
0,047  0,005  Elastase 2B inhibitor
0,047  0,005  Elastase 3A inhibitor
0,047  0,005  Elastase 3B inhibitor
0,097  0,055  Antiviral (Rhinovirus)
0,091  0,050  Antineoplastic antibiotic
0,088  0,047  Acetylcholine nicotinic antagonist
0,059  0,019  Leukocyte elastase inhibitor
0,101  0,062  Sulfotransferase substrate
0,125  0,085  Sphingosine 1-phosphate receptor 2 antagonist
0,057  0,018  Dopamine beta hydroxylase inhibitor
0,062  0,024  Carbonic anhydrase XIV inhibitor
0,068  0,030  Alcohol oxidase inhibitor
0,194  0,156  Antimycobacterial
0,092  0,054  NADH dehydrogenase inhibitor
0,077  0,040  Phospholipase D inhibitor
0,129  0,092  Peroxidase inhibitor
0,052  0,015  Dihydropteroate synthase inhibitor
0,176  0,140  Antineoplastic (colon cancer)
0,046  0,009  HMG CoA reductase inhibitor
0,059  0,024  Vanilloid 2 antagonist
0,114  0,080  Epidermal growth factor receptor kinase inhibitor
0,057  0,023  Squalene epoxidase inhibitor
0,082  0,049  Macrophage migration inhibitory factor inhibitor
0,038  0,005  Lysophosphatidic acid 1 receptor antagonist
0,073  0,040  Carbonic anhydrase V inhibitor
0,244  0,212  Calcium channel L-type activator
0,260  0,228  Antineoplastic (solid tumors)
0,064  0,032  Ribonucleoside-diphosphate reductase inhibitor
0,047  0,015  Retinoid X receptor antagonist
0,072  0,040  SULT2A1 substrate
0,091  0,060  Paget's disease treatment
0,208  0,176  Interleukin 2 agonist
0,093  0,062  Breast cancer-resistant protein inhibitor
0,062  0,031  Lipocortins synthesis agonist
0,065  0,034  Ribonucleotide reductase inhibitor
0,039  0,009  Prostaglandin EP2 agonist
0,116  0,085  Retinoprotector
0,046  0,016  Retinoid X alpha receptor agonist
0,087  0,057  Epidermal growth factor antagonist
0,033  0,003  Thromboxane A2 agonist
0,083  0,053  Sleep apnea treatment
0,047  0,018  GABA uptake inhibitor
0,063  0,034  Fibroblast growth factor 4 antagonist
0,095  0,066  Sphingomyelinase inhibitor
0,035  0,006  Prostaglandin EP4 agonist
0,039  0,012  Leukotriene B4 receptor 1 antagonist
0,117  0,089  Antihelmintic (Trematoda)
0,046  0,018  Kainate receptor 2 antagonist
0,109  0,082  MAO inhibitor
0,031  0,004  Neuraminidase (Influenza B) inhibitor
0,126  0,100  Acetylcholine M1 receptor antagonist
0,089  0,064  Antiviral (Hepatitis A)
0,079  0,054  Cell adhesion molecule inhibitor
0,221  0,196  Antiprotozoal
0,068  0,044  MDM2 inhibitor
0,059  0,035  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,124  0,100  Diuretic
0,062  0,038  Potassium channel intermediate-conductance Ca-activated blocker
0,060  0,037  VEGFR2 expression inhibitor
0,038  0,015  Prostaglandin EP3 antagonist
0,161  0,138  Antiviral (HIV)
0,042  0,019  Vanilloid 3 antagonist
0,069  0,046  Gaucher disease treatment
0,035  0,013  Prostaglandin EP4 antagonist
0,042  0,019  VCAM-1 antagonist
0,038  0,015  ATP citrate lysase inhibitor
0,039  0,016  Retinoid X alpha receptor antagonist
0,046  0,024  Kainate receptor antagonist
0,042  0,020  VCAM antagonist
0,101  0,078  SULT1A1 substrate
0,174  0,152  Antituberculosic
0,061  0,039  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,031  0,009  Vanilloid 2 agonist
0,050  0,028  Microtubule stabilization
0,122  0,100  Farnesoid X receptor antagonist
0,123  0,102  Antiprotozoal (Coccidial)
0,077  0,056  Metalloproteinase-2 inhibitor
0,110  0,090  Cyclooxygenase 1 inhibitor
0,056  0,036  Dihydroorotate oxidase inhibitor
0,040  0,020  Integrin alpha1beta1 antagonist
0,031  0,012  Prostaglandin H2 antagonist
0,040  0,021  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,027  0,008  Isoleucine-tRNA ligase inhibitor
0,023  0,004  Carbonic anhydrase XI inhibitor
0,057  0,037  Maillard reaction inhibitor
0,054  0,035  Nicotinic alpha3beta2 receptor antagonist
0,169  0,149  Peptidyltransferase inhibitor
0,104  0,085  Menstruation disorders treatment
0,112  0,093  NADPH oxidase inhibitor
0,119  0,100  Pancreatic disorders treatment
0,040  0,021  Inosine monophosphate dehydrogenase inhibitor
0,035  0,016  Epoxide hydrolase 1 inhibitor
0,036  0,018  Melatonin 1 agonist
0,041  0,023  5-Alpha-reductase inhibitor
0,032  0,014  Kynurenine 3 monooxygenase inhibitor
0,052  0,034  Glucose-6-phosphate translocase inhibitor
0,070  0,052  Calcium channel L-type blocker
0,127  0,109  Pregnane X receptor agonist
0,056  0,039  Acetyl-CoA transferase 2 inhibitor
0,048  0,031  Benzodiazepine antagonist
0,049  0,031  Glycine transporter 2 inhibitor
0,058  0,041  Beta tubulin antagonist
0,027  0,011  Elastase 2 inhibitor
0,027  0,011  Elastase 2A inhibitor
0,024  0,008  Retinoid X beta receptor antagonist
0,089  0,074  Aminopeptidase B inhibitor
0,029  0,013  Toll-Like receptor 4 agonist
0,061  0,046  NMDA receptor agonist
0,052  0,038  Acetyl-CoA transferase inhibitor
0,021  0,006  Vitamin D receptor agonist
0,044  0,030  Dihydrofolate reductase inhibitor
0,162  0,148  Antiviral (Ebola)
0,120  0,107  SULT1A3 substrate
0,017  0,004  Calcineurin inhibitor
0,088  0,075  Anticataract
0,058  0,046  Neuraminidase inhibitor
0,071  0,058  CYP2A6 inhibitor
0,043  0,031  Geranyltranstransferase inhibitor
0,017  0,004  Thromboxane agonist
0,104  0,092  Shock treatment
0,043  0,031  AICAR transformylase inhibitor
0,068  0,056  Epoxide hydrolase inhibitor
0,107  0,095  Cathepsin H inhibitor
0,168  0,156  Nitric-oxide synthase stimulant
0,028  0,016  Nicotinic acid receptor 2 antagonist
0,063  0,051  Uterine relaxant
0,137  0,126  Aldehyde oxidase substrate
0,178  0,167  Antineoplastic (sarcoma)
0,042  0,031  Guanylate cyclase inhibitor
0,054  0,044  Dopamine uptake inhibitor
0,110  0,100  Antiviral (Papilloma)
0,033  0,024  Sodium-dependent vitamin C transporter 2 inhibitor
0,030  0,021  Peptide deformylase inhibitor
0,034  0,025  Phosphoglycerate kinase inhibitor
0,093  0,084  Antihelmintic (Fasciola)
0,028  0,020  Liver X receptor beta antagonist
0,035  0,027  Nicotinic acid receptor agonist
0,047  0,039  Cytokine production stimulant
0,051  0,044  Matrix metalloproteinase (membrane-type) inhibitor
0,073  0,066  Chymotrypsin inhibitor
0,148  0,141  Aldehyde oxidase inhibitor
0,048  0,042  Prostaglandin antagonist
0,086  0,079  Protease inhibitor
0,060  0,055  Beta adrenoreceptor antagonist
0,020  0,015  Toll-Like receptor 8 agonist
0,013  0,008  Calcium-dependent phospholipase A2 inhibitor
0,046  0,042  Prolyl endopeptidase inhibitor
0,062  0,058  Glutamate (mGluR7) antagonist
0,038  0,034  Acetyl-CoA transferase 1 inhibitor
0,024  0,020  Leukotriene D4 antagonist
0,020  0,016  Factor XIII inhibitor
0,030  0,027  Melatonin agonist
0,037  0,035  Liver X receptor alpha agonist
0,027  0,025  Liver X receptor alpha antagonist
0,049  0,047  Alpha-mannosidase inhibitor
0,145  0,144  Antiparkinsonian, rigidity relieving
0,156  0,155  VEGF expression inhibitor
0,031  0,030  Arginase inhibitor
0,025  0,024  Retinoid X gamma receptor antagonist
0,084  0,083  UDP-glucose 4-epimerase inhibitor

